Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,500
Closed -$21.9K 1140
2026
Q1
$21.9K Buy
+7,500
New +$21.4K ﹤0.01% 832
2021
Q4
Sell
-1,400
Closed -$4K 1072
2021
Q3
$4K Hold
1,400
﹤0.01% 916
2021
Q2
$5K Hold
1,400
﹤0.01% 882
2021
Q1
$4K Hold
1,400
﹤0.01% 957
2020
Q4
$4K Buy
1,400
+951
+212% +$2.56K ﹤0.01% 940
2020
Q3
$1K Buy
+449
New +$1.13K ﹤0.01% 975
2020
Q2
Sell
-12,000
Closed -$28K 860
2020
Q1
$28K Sell
12,000
-500
-4% -$1.81K ﹤0.01% 583
2019
Q4
$58K Sell
12,500
-6,000
-32% -$26.6K ﹤0.01% 558
2019
Q3
$85K Sell
18,500
-6,000
-24% -$28.7K ﹤0.01% 500
2019
Q2
$114K Sell
24,500
-7,118
-23% -$31.9K ﹤0.01% 474
2019
Q1
$136K Buy
+31,618
New +$145K 0.01% 232
2018
Q4
Sell
-80,350
Closed -$367K 151
2018
Q3
$367K Buy
+80,350
New +$383K 0.02% 252
2018
Q2
Sell
-139,350
Closed -$1.01M 345
2018
Q1
$1.01M Sell
139,350
-18,070
-11% -$124K 0.04% 180
2017
Q4
$1.02M Sell
157,420
-5,265
-3% -$33.7K 0.04% 186
2017
Q3
$1.07M Sell
162,685
-6,792
-4% -$42.1K 0.05% 178
2017
Q2
$930K Sell
169,477
-24,482
-13% -$140K 0.04% 186
2017
Q1
$1.12M Sell
193,959
-7,550
-4% -$41.4K 0.05% 175
2016
Q4
$990K Sell
201,509
-66,623
-25% -$360K 0.05% 184
2016
Q3
$1.63M Sell
268,132
-43,738
-14% -$261K 0.08% 151
2016
Q2
$1.84M Sell
311,870
-260,249
-45% -$1.4M 0.09% 136
2016
Q1
$2.96M Sell
572,119
-117,813
-17% -$542K 0.15% 109
2015
Q4
$3.08M Sell
689,932
-764,748
-53% -$3.74M 0.16% 112
2015
Q3
$7.13M Sell
1,454,680
-56,917
-4% -$309K 0.39% 70
2015
Q2
$9.22M Buy
1,511,597
+122,660
+9% +$758K 0.46% 64
2015
Q1
$8M Buy
1,388,937
+354,101
+34% +$2.2M 0.4% 71
2014
Q4
$6.44M Buy
+1,034,836
New +$6.54M 0.32% 80

Other funds holding ABEV

HM Payson & Co's ABEV Position: Q2 2026 in Review

HM Payson & Co sold out of Ambev (ABEV) in Q2 2026, closing a stake of 7,500 shares — an estimated $21.9K sold.

HM Payson & Co first reported a position in ABEV in Q4 2014 and held it in 26 quarters. The position peaked at $9.22M in Q2 2015. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • HM Payson & Co reported no remaining Ambev position as of Q2 2026 after selling out during the quarter.
  • HM Payson & Co sold 7,500 Ambev shares in Q2 2026, an estimated $21.9K.
  • HM Payson & Co first reported a position in Ambev in Q4 2014 and held it in 26 quarters.
  • HM Payson & Co's Ambev position peaked at $9.22M in Q2 2015.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.